| Catalog Number |
D138505 |
| Medical Device Problem Code |
Material Separation (1562)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/18/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
| |
|
Event or Problem Description
|
|
It was reported that a patient underwent a cardiac ablation procedure with a vizigo sheath and the hemostatic valve became dislodged.This occurred one hour after the catheter use, at the time of replacement.The sheath had been used on the patient.No air entered the patient's body.No blood return was observed.The sheath was replaced and the remainder of the procedure was successfully completed.No patient consequences were reported.
|
| |
|
Additional Manufacturer Narrative
|
|
On 19-mar-2026, the bwi product analysis lab received the device for evaluation.The product investigation was subsequently completed.It was reported that a patient underwent a cardiac ablation procedure with a vizigo sheath and the hemostatic valve became dislodged.This occurred one hour after the catheter use, at the time of replacement.The sheath had been used on the patient.No air entered the patient's body.No blood return was observed.The sheath was replaced and the remainder of the procedure was successfully completed.No patient consequences were reported.Device evaluation details: the device was returned to johnson & johnson medtech (j&j medtech) for evaluation.Visual inspection, back pressure test, and microscopic examination of the returned device were performed following j&j medtech procedures.Visual analysis of the returned sample revealed that no damage was observed, and the hemostatic valve was observed in place.Microscopic examination of the hemostatic valve surface does not show stress marks on the outer diameter.A back pressure test was performed, and no leakage or issues were observed.A device history review was performed for the finished device number lot 60000755 and no internal action related to the complaint was found during the review.There was no hemostatic valve separation detected.The complaint was not duplicated, and it could not be confirmed; other issues or circumstances may have occurred during the usage of the device that compromised its performance.The instructions for use contain the following warning stated in the ifu (instructions for use): use best practices for inserting or retracting any device at the hemostatic valve.Monitor any potential air entrapped and completely aspirate any observed air out of the side port; do not remove dilator or catheter rapidly.Damage to hemostatic valve may occur.As part of johnson & johnson medtech¿s quality process, all devices are manufactured, inspected, and released to approved specifications.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
| |
|
Search Alerts/Recalls
|